First-ever ACG recommendations establish evidence-based protocols for diagnosing and managing gastric atrophy, intestinal metaplasia, and dysplasia, addressing significant cancer disparities in high-risk U.S. populations
"Chronic ethanol intake, through one of its main metabolic products, acetaldehyde, causes pathological changes in the gastrointestinal tract, liver, pancreas, and gallbladder. Even moderate amounts of alcohol may increase the risk of cancers, such as colorectal cancer."
New meta-analysis of 42 studies finds no overall difference in cancer risk between red and white wine consumption, despite long-held beliefs about resveratrol's protective effects; white wine consumption significantly linked to increased skin cancer risk.
Cabozantinib significantly reduced disease progression risk in patients with advanced neuroendocrine tumors: A 62% lower risk in extrapancreatic NETs and 77% in pancreatic NETs, study authors report.
Preclinical study demonstrates that aspirin may prevent cancer metastasis by inhibiting platelet-produced TXA2, which normally suppresses T-cell immunity against spreading cancer cells.